Display options
Cite
Hart KM, Choy DF, Bradding P, et al. Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma. Ann Transl Med. 2017;5(4):91doi: 10.21037/atm.2017.02.07.
Hart, K. M., Choy, D. F., Bradding, P., Wynn, T. A., & Arron, J. R. (2017). Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma. Annals of translational medicine, 5(4), 91. https://doi.org/10.21037/atm.2017.02.07
Hart, Kevin M, et al. "Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma." Annals of translational medicine vol. 5,4 (2017): 91. doi: https://doi.org/10.21037/atm.2017.02.07
Hart KM, Choy DF, Bradding P, Wynn TA, Arron JR. Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma. Ann Transl Med. 2017 Feb;5(4):91. doi: 10.21037/atm.2017.02.07. PMID: 28275636; PMCID: PMC5337223.
Copy Download .nbib Format: NLM
Share it on

Ann Transl Med. 2017 Feb;5(4):91. doi: 10.21037/atm.2017.02.07.

Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma.

Annals of translational medicine

Kevin M Hart, David F Choy, Peter Bradding, Thomas A Wynn, Joseph R Arron

Affiliations

  1. Program in Tissue Immunity and Repair, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  2. Genentech, Inc. South San Francisco, CA 94080, USA.
  3. Institute for Lung Health, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester LE3 9QP, UK.

PMID: 28275636 PMCID: PMC5337223 DOI: 10.21037/atm.2017.02.07

[No abstract available.]

Conflict of interest statement

Conflicts of Interest: DFC and JRA are employees of Genentech, Inc., hold stock and/or stock options in the Roche Group, and are named inventors on patents pending related to asthma biomarkers and tre

References

  1. Am J Respir Crit Care Med. 2013 Dec 1;188(11):1294-302 - PubMed
  2. Eur Respir J. 1999 Jun;13(6):1245-52 - PubMed
  3. Ann Am Thorac Soc. 2013 Dec;10 Suppl:S206-13 - PubMed
  4. J Clin Invest. 2015 Aug 3;125(8):3037-50 - PubMed
  5. J Allergy Clin Immunol. 2014 Oct;134(4):975-8.e5 - PubMed
  6. Sci Transl Med. 2016 May 4;8(337):337ra65 - PubMed
  7. J Allergy Clin Immunol. 2015 Jul;136(1):59-68.e14 - PubMed
  8. J Gen Intern Med. 2014 Feb;29(2):388-94 - PubMed
  9. J Allergy Clin Immunol. 2012 Jan;129(1):104-11.e1-9 - PubMed
  10. Am J Respir Crit Care Med. 1996 Jul;154(1):224-30 - PubMed
  11. J Immunol. 2014 Jul 1;193(1):111-9 - PubMed
  12. Lancet Respir Med. 2016 Oct;4(10 ):781-796 - PubMed
  13. N Engl J Med. 2009 Mar 5;360(10):973-84 - PubMed
  14. J Allergy Clin Immunol. 2008 Aug;122(2):335-41, 341.e1-3 - PubMed
  15. Am J Respir Crit Care Med. 2012 Mar 15;185(6):612-9 - PubMed
  16. Eur Respir J. 2014 Feb;43(2):627-9 - PubMed
  17. J Allergy Clin Immunol. 2016 Oct 1;:null - PubMed
  18. Clin Pharmacokinet. 2011 Apr;50(4):215-27 - PubMed
  19. Biomark Med. 2016;10 (2):165-76 - PubMed
  20. J Allergy Clin Immunol. 1991 Oct;88(4):661-74 - PubMed
  21. Eur Respir J. 2016 May;47(5):1383-91 - PubMed
  22. Sci Transl Med. 2015 Aug 19;7(301):301ra129 - PubMed
  23. J Clin Invest. 2016 Sep 1;126(9):3279-95 - PubMed
  24. Nat Immunol. 2014 Oct;15(10):938-46 - PubMed
  25. J Allergy Clin Immunol. 2014 Nov;134(5):1175-1186.e7 - PubMed

Publication Types